Agilent, Bristol-Myers sales and marketing update

Agilent’s Dako company launched PD-L1 IHC 28-8 pharmDx in the EU to detect PD-L1 expression levels. The test was developed with Bristol-Myers Squibb to assess the survival benefit associated with the...